Subsequently, GPX4 expression was validated in CRC tissues, adjacent normal tissues, and cell lines with varying metastatic potentials using immunohistochemistry (IHC), qRT-PCR, and Western blotting. This evidence concerns the gene GPX4 and colorectal carcinoma.